Jason Gardner

Jason Gardner, D. Phil. is the Chief Executive Officer and Co-founder of Magenta Therapeutics. He has more than 20 years of experience in stem cell science and industry leadership roles. He worked at Glaxo Smith Kline for 11 years, most recently as Vice President and Head of the R&D Satellite in Boston. He created and led the Regenerative Medicine Unit, and established partnerships with The Harvard Stem Cell Institute, and The Telethon Institute for Gene Therapy, from which the first stem cell medicine (Strimvelis™) was approved. Prior to that, Dr. Gardner was the Head of the Center of Excellence for External Drug Discovery (CEEDD) and was a member of the clinical project team that led the late-stage development and NDA approval for Tykerb™ for breast cancer. He completed a postdoctoral fellowship in hematopoietic stem cells with Professor David Scadden at Harvard Medical School. Dr. Gardner was educated in the U.K. and holds a doctorate from Oxford University and graduate and undergraduate degrees from Cambridge University.